Clinical trials by condition
Long COVID clinical trials near you
42 studies for long COVID are recruiting volunteers at 55 research sites in 25 states.
Also called post-COVID condition, post-acute sequelae of COVID-19, PASC, long-haul COVID.
A type of COVID-19
- Studies recruiting
- 42
- Research sites
- 55
- States
- 25
What is long COVID?
Long COVID is a chronic (long-lasting) condition that can be diagnosed when symptoms of COVID-19 last for at least three months. It can be mild or severe. Symptoms may last from the start, go away and come back, or first appear months after the infection.
Symptoms vary widely and can affect many parts of the body. They include tiredness, fever, breathing problems, cough, heart symptoms, brain fog (trouble thinking and concentrating), headaches, sleep problems and digestive problems. Some symptoms are like those of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Symptoms often get better over time, but some people, including children, become disabled.
Anyone who had COVID-19 can get it. The risk is higher for women, Hispanic or Latino people, people who had severe COVID-19 or other health conditions before, people who were not vaccinated, and people who had multisystem inflammatory syndrome. There is no specific test: it is diagnosed from a person's medical history, a physical exam and sometimes blood or imaging tests, and diagnosis can take time. There is no specific treatment; care focuses on managing symptoms and quality of life.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 17, 2026. Read more on MedlinePlus
Areas with the most long COVID studies
Metro areas where studies for long COVID are recruiting, each study counted once in an area.
By state
Studies for long COVID recruiting in each state.
- California12 studies · 12 sites
- Maryland6 studies · 5 sites
- New York6 studies · 4 sites
- Massachusetts5 studies · 4 sites
- Arizona2 studies · 2 sites
- Colorado2 studies · 2 sites
- Florida2 studies · 2 sites
- Illinois2 studies · 2 sites
- Minnesota2 studies · 2 sites
- Tennessee2 studies · 2 sites
Whom the studies accept
The share of the long COVID studies open to each group. A study can accept several.
- Adults 18 to 64100%
- Adults 65 and over95%
- Children and teens (under 18)12%
- Healthy volunteers33%
- Open to all sexes100%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Early phase 12%
- Phase 15%
- Phase 1/22%
- Phase 219%
- Phase 2/32%
- Phase 37%
- Phase 42%
- No phase (device, behavioral and other studies)38%
- Not stated21%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Long COVID clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/long-covid, updated November 17, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/long-covid">LocalTrial, Long COVID clinical trials near you</a>, updated November 17, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study long COVID. A study is counted once however many sites it has.
Updated November 17, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the long COVID studies near you that may fit. Free and private.
Ready to see what's near you?
Find long COVID studies near me